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Abstract
BACKGROUND—Deep layer excitatory circuits in the prefrontal cortex represent the strongest 
locus for genetic convergence in autism, but specific abnormalities within these circuits that 
mediate key features of autism, such cognitive or attentional deficits, remain unknown. Attention 
normally increases the sensitivity of neural populations to incoming signals by decorrelating 
ongoing cortical circuit activity. Here we investigated whether mechanisms underlying this 
phenomenon might be disrupted within deep layer prefrontal circuits in mouse models of autism.
METHODS—We isolated deep layer prefrontal circuits in brain slices then used single-photon 
GCaMP imaging to record activity from many (50-100) neurons simultaneously, in order to study 
patterns of spontaneous activity generated by these circuits under normal conditions and in two 
etiologically distinct models of autism: mice exposed to valproic acid (VPA) in utero and FMR1 
KO mice.
RESULTS—We found that modest doses of the cholinergic agonist carbachol normally 
decorrelate spontaneous activity generated by deep layer prefrontal networks. This effect was 
disrupted in both VPA-exposed and FMR1 KO mice, but intact following other manipulations 
which do not model autism.
CONCLUSIONS—Our results suggest that cholinergic modulation may contribute to attention 
by acting on local cortical microcircuits to decorrelate spontaneous activity. Furthermore, defects 
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in this mechanism represent a microcircuit-level endophenotype that could link diverse genetic 
and developmental disruptions to attentional deficits in autism. Future studies could elucidate 
pathways leading from various etiologies to this circuit-level abnormality, or use this abnormality 
itself as a target, and identify novel therapeutic strategies that restore normal circuit function.
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calcium imaging; GCaMP; prefrontal cortex; Fragile X syndrome; acetylcholine; valproic acid
INTRODUCTION
Autism reflects disparate genetic and environmental causes, suggesting that common 
behavioral phenotypes may reflect convergent defects at the level of neuronal circuits 
controlling these behaviors. Consistent with this hypothesis, recent analyses have revealed 
that several genes linked to autism are co-expressed within deep layer microcircuits in the 
prefrontal cortex (PFC) (1, 2). Identifying convergent abnormalities located within these 
microcircuits would yield attractive targets for future circuit-based therapeutic interventions. 
Until recently, a major barrier to identifying such circuit-level abnormalities has been 
recording from large numbers of neurons simultaneously. However, advances in imaging 
and electrophysiological techniques have made it possible to characterize patterns of circuit-
level activity by, for example, calculating correlations between neurons (3, 4). Despite these 
advances, cognitive processes are associated with complex neural dynamics embedded 
within a high dimensional state space. Thus, in order to reveal defects in circuit-level 
activity that are associated with disorders such as autism, it is valuable to first identify 
specific neuronal correlates or signatures for relevant cognitive processes. Identifying these 
signatures makes it possible to evaluate whether they are altered in the setting of diseases 
such as autism. Any such alterations represent putative pathophysiological mechanisms 
contributing to cognitive dysfunction in these disease states.
Here, we set out to identify possible microcircuit-level abnormalities associated with autism. 
Our approach was to look for convergent abnormalities that are 1) conserved across 
multiple, etiologically distinct models of autism, and 2) impact neural correlates of cognitive 
processes that are known to be abnormal in autism. In particular, two recent studies 
identified a possible neural signature of attention using multi-neuronal recording in monkeys 
performing a visuospatial attention task (5, 6). Both studies observed the same result: during 
the attended portion of the task, the pairwise correlations between cortical neurons 
decreased. This decorrelation would reduce the overall noise of an output signal that was 
composed of a sum across the population – in fact, this pairwise decorrelation accounted for 
80% of the total improvement in the signal-to-noise ratio (6). This phenomenon is 
hypothesized to reflect the decorrelation of spontaneous network activity by 
neuromodulation. In particular, cholinergic modulation plays a well-established role in 
attention and cortical decorrelation in vivo (7). Nevertheless, it remains unknown whether 
cholinergic modulation can induce such decorrelations by acting directly on cortical 
microcircuits and if so, whether defects in this mechanism might be present in autism or 
other conditions with a high comorbidity of attentional deficits. Notably, in Fragile X 
syndrome (the most common known single gene cause of autism), 70% of affected children 
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meet criteria for an attentional deficit (8). Overall, approximately 50% of children with 
autism also meet criteria for attention deficit hyperactivity disorder (8). Deficits in attention 
have also been observed in FMR1 KO mice (9-11) and other mouse models of autism (12).
To examine how autism might affect a neural correlate of attention, we studied how 
cholinergic modulation affects spontaneous activity generated by deep layer prefrontal 
microcircuits under normal conditions and in mouse models of autism. We focused on 
microcircuits in deep layers of the PFC because cholinergic modulation within the PFC has 
been directly implicated in attention (13, 14), and abnormalities associated with autism are 
likely to be intrinsic to deep layer prefrontal microcircuits (1). Therefore, we isolated these 
microcircuits in brain slices, and used single-photon, wide field GCaMP imaging (15) to 
measure spontaneous activity in many neurons (50-100) at once. As described below, we 
found that cholinergic modulation can indeed act directly on cortical microcircuits to 
decorrelate spontaneous activity, mimicking the neural signature previously linked to 
attention in vivo. Furthermore, this decorrelation, which represents a possible neural 
substrate for attention, is defective in two etiologically distinct mouse models of autism.
MATERIALS AND METHODS
All experiments were conducted in accordance with procedures established by the 
Administrative Panels on Laboratory Animal Care at the University of California, San 
Francisco.
Subjects
P26-33 mice of either sex (Charles River) were injected unilaterally with 500 nL of AAV5/2
—synapsin::GCaMP6s (UNC viral vector core) at the coordinates (in mm): 1.7 anterior-
posterior (AP), 0.3 mediolateral (ML), and −2.2 dorsoventral (DV). Experiments studying 
the valproic acid (VPA) model of autism used C57BL/6 mice whose pregnant mothers had 
been injected with a single dose of VPA (500 mg/kg i.p.) at E10.5. For these experiments, 
control mice were C57BL/6 mice whose pregnant mothers had been injected with saline at 
E10.5. VPA solution was prepared by dissolving VPA in 0.9% saline to a final concentration 
of 150 mg/mL. Experiments studying a mouse model of Fragile X syndrome used male 
FMR1 WT or KO mice on a FVB background (Jackson labs). In some cases (active ACSF 
cohorts), these FMR1 WT and KO mice were littermates, while others (carbachol cohorts) 
were not.
For some experiments, C57Bl/6 mice were treated with fluoxetine based on a previously 
described protocol (16). Fluoxetine was administered (5 mg kg−1, I.P.) once daily for 6 days 
prior to imaging with the final injection coming 24-48 hours before imaging. Dominant 
negative DISC1 mutant mice were generated by crossing B6-CamKII::TtA (JAX: 00310) 
mice with tetO-DISC1dn (JAX: 008790) to yield mice expressing dominant negative DISC1 
in neocortical pyramidal cells.
Slice preparation
In all cases, 350 micron thick coronal slices were prepared from these animals 15-27 days 
after injection (6-8 weeks of age). Slices preparation followed our previously described 
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protocol (17) with one deviation: immediately after brain slices were prepared, they were 
transferred to an N-Methyl-D-Glucamine (NMDG)-based recovery solution for 10 min 
before being transferred to ACSF for the remainder of their recovery (18). The NMDG-
based solution was maintained at 32° C, and consisted of the following (in mM): 93 N-
Methyl-D-Glucamine (NMDG), 93 HCl, 2.5 KCl, 1.2 NaH2PO4, 30 NaHCO3, 25 glucose, 
20 HEPES, 5 Na-ascorbate, 5 Na-pyruvate, 2 thiourea, 10 magnesium sulfate, 0.5 calcium 
chloride. This NMDG preparation method was used to improve the overall health of adult 
slices to ensure sufficient amounts of activity for analysis. ACSF contained the following (in 
mM): 126 NaCl, 26 NaHCO3, 2.5 KCl, 1.25 NaH2PO4, 1 MgCl2, 2 CaCl, and 10 glucose. 
All recordings were at 32.5 +/− 1°C. “Active” ACSF was identical to normal ACSF except 
with elevated KCl (3.5mM vs. 2mM) and reduced CaCl (1.2mM vs. 2mM).
Imaging
GCaMP imaging was performed on an Olympus BX51 upright microscope with a 20× 
1.0NA water immersion lens, 0.5× reducer (Olympus), and ORCA-ER CCD Camera 
(Hamamatsu Photonics). Illumination was delivered using a Lambda DG4 arc lamp (Sutter 
Instruments). Light was delivered through a 472/30 excitation filter, 495nm single band 
dichroic, and 496nm long pass emission filter (Semrock).
All movies that were analyzed consisted of 36000 frames acquired at 10Hz (1 hr) with 4×4 
sensor binning yielding a final resolution of 256 × 312 pixels. Light power during imaging 
was 100 – 500 μW/mm2. The Micro Manager software suite (v1.4, NIH) was used to control 
all camera parameters and acquire movies Any movies that had significant drift (greater than 
~0.25 soma diameters), movement, or lacked significant amounts of activity were excluded 
from further analysis. Significant movement could be detected during independent 
components analysis (ICA) by the appearance of elliptical rather than circular segments. We 
observed that active, GCaMP-expressing neurons were found within a discrete layer (c.f. 
Fig. 1A) consistent with the location of layer 5 in medial prefrontal cortex.
Signal extraction
All analyses and signal extraction was performed using MATLAB (Mathworks). Locations 
of cells were automatically identified using a modified version of the published CellSort 1.1 
toolbox (19). In particular, a factor, μ, specifies the weight between spatial and temporal 
sparseness: μ = 0 is purely spatial and μ = 1 is purely temporal. All of our analyses used μ = 
0.2 which was within the optimal range outlined in (19). Signals were extracted from movies 
and the baseline fluorescence function, F0, was calculated for every trace using the mode of 
the kernel density estimate over a 100s rolling window, implemented via the MATLAB 
function ksdensity following the procedure outlined in (20). All signal traces shown 
represent normalized versions of the (F-F0)/F0 trace.
Threshold based event detection was performed on the traces by detecting increases in (F-
F0)/F0 exceeding 2.5σ over one second, and then further thresholding these events by 
keeping only those events which exceeded a 4σ increase over two seconds. σ is the standard 
deviation of (F-F0)/F0, calculated over the entire movie. Thus all detected events have a 
deviation of at least 4σ from baseline. After identifying these events in the calcium signal 
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from a cell, the cell was considered “active” during the entire period from the beginning to 
the peak of the event. The beginning of the event was defined as the first point for which (F-
F0)/F0 increases by 2.5σ within 1 second and by 4σ within 2 seconds. The peak of the event 
was defined as the local maximum of the entire event, from the beginning of the event until 
(F-F0)/F0 returns to the same baseline value. We then created a matrix in which each row 
corresponds to a neuron, and each column corresponds to a frame. Entries in this matrix 
were 1 if a given neuron was active during a given frame, and 0 otherwise. All subsequent 
analyses were performed on this two-dimensional representation of network activity over 
time (c.f. Fig. 1C).
Correlations between cells were calculated between the binary event trains corresponding to 
those two cells after subtracting the mean level of activity from each event train.
The standard deviation projection in Figure 1 was obtained as follows. For each pixel, we 
computed the standard deviation of (F-F0)/F0 over 30 second intervals throughout the first 
10 minutes of a movie, then plotted the maximum value of these standard deviations.
Statistical analysis
Unless otherwise noted, we used the Mann Whitney U-test to compare pairs of groups, 
repeated measures ANOVA to compare multiple groups, and the two-tailed Kolmogorov-
Smirnov (KS) test to compare pairs of distributions. To compare the number of strong 
correlations between conditions, we treated the fraction of strong correlations in each slice 
as an observation. Error bars where shown indicate standard error unless otherwise noted. 
Cell identification, signal extraction and normalization, event detection, and all other data 
analysis was done using fully automated routines that were independent of the investigator 
and thus blinded.
RESULTS
We recorded sparse, robust GCaMP signals from neurons in layer 5 (L5) of the medial 
prefrontal cortex (mPFC; Fig. 1) in acute brain slices from late adolescent (P41-57) mice (n 
= 95). Using a combination of independent component analysis (ICA) and image 
segmentation (19), we located neurons, measured their GCaMP signals, and detected events 
corresponding to increased activity in these neurons (Fig. 1A-C). Each experiment recorded 
from 50-100 active L5 neurons for 1 hour. Table 1 lists all of our experiments, performed in 
control mice or mice modeling autism or other manipulations, and using either carbachol or 
high K+ ACSF to elicit spontaneous activity. Table 1 also includes summary statistics for 
each set of experiments.
We first sought to demonstrate the presence of correlated activity within our datasets. 
Experiments contained more strong correlations than shuffled datasets, in which the event 
train for each neuron is shifted in time by a different random amount, or scrambled datasets, 
in which the neuronal identities associated with each event are randomly reassigned (Fig 
1D). Shuffled datasets preserve the temporal structure of activity within each neuron, 
whereas scrambled datasets preserve the number of neurons active at any given point in 
time, thus maintaining the temporal structure of activity at the network level. We set an 
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arbitrary threshold of 0.15, and quantified the fraction of correlations exceeding this 
threshold. As shown in Fig. 1D, correlations exceeding this threshold were present at 
negligible levels in shuffled or scrambled datasets, so we used this threshold to define 
“strong” correlations, i.e. correlations which exceed those expected simply by chance.
Given the posited link between cholinergic modulation and cortical circuit decorrelation, we 
next compared spontaneous prefrontal microcircuit activity elicited by 2 μM carbachol to 
activity in “active ACSF” (21), which contains relatively high K+ and low Ca2+. Active (or 
high K+) ACSF elicits similar levels of spontaneous activity as 2 μM cabrachol (avg % time 
active = 4.2 ± 0.3 in carbachol vs. 4.5 ± 0.5 in high K+), making it possible to compare the 
properties of such activity when cholinergic modulation is present or absent, independent of 
changes in activity levels. These experiments, comparing recordings in carbachol to those in 
high K+, were all done using WT mice on an FVB background, which served as controls for 
experiments with FMR1 KO mice described below. Consistent with our hypothesis that 
cholinergic modulation decorrelates prefrontal microcircuit activity, the distribution of 
pairwise correlations was shifted to the right in high K+ compared to carbachol (Fig. 2A). 
This resulted in a marked increase in the fraction of “strong” correlations (correlations 
>0.15), from 1.2 ± 0.3% in carbachol to 4.0 ± 0.9% in high K+ (Fig. 2A inset).
Notably the decrease in correlations observed in carbachol was not an artifact of differences 
in activity. Plotting the fraction of strong correlations against the mean % time activity for 
each experiment in carbachol or high K+ shows that the fraction of strong correlations is 
increased in high K+ compared to carbachol, for all activity levels (Fig. 2D). To 
quantitatively and explicitly account for possible confounding effects of activity on the 
prevalence of strong correlations, we performed linear regression (Fig. 2D), and computed 
the difference between the observed fraction of strong correlations and the number expected 
based simply on the level of activity. These residual values are shown in Fig. 2E, and 
confirm that even when activity levels are taken into account, correlations in high K+ are 
stronger than those in carbachol.
Next, we examined whether this carbachol-induced decorrelation, which represents a 
possible biological substrate for attention, might be disrupted in in two etiologically 
dissimilar mouse models of autism. First, we studied mice exposed to valproic acid (VPA) 
in utero at E10.5 (Methods). VPA is an anticonvulsant and mood stabilizer, and there is a 
markedly elevated rate of autism in the children of mothers treated with VPA (but not other 
anticonvulsants) during pregnancy (22-24). Rodents exposed to VPA in utero exhibit 
numerous autism-like phenotypes (25, 26). We also studied FMR1 KO mice, which model 
Fragile X syndrome, the most common known genetic cause of autism (27).
In stark contrast to the carbachol-induced decorrelation described earlier, in both VPA-
exposed and FMR1 KO slices, carbachol failed to elicit a leftward shift of the correlation 
distribution (Fig. 2B,C). In fact, carbachol increased correlations in the VPA-exposed 
microcircuits (Fig. 2C). A potentially complicating factor is that unlike the case in wild-type 
slices, in both VPA-exposed and FMR1 KO slices, levels of activity were lower in carbachol 
compared to high K+ ACSF. We calculated correlations using mean subtracted even trains, 
which should minimize activity level-dependent effects. Indeed, as Fig. 2D shows, there is at 
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best a very weak relationship between activity levels and correlations. We also carried out 
additional analyses described in the Supplemental Information which confirm that the 
absence of a carbachol-induced decorrelation in autism models was not simply an artifact of 
differences in activity levels (Fig. S1).
We reasoned that this loss of the carbachol-induced decorrelation should cause correlations 
during carbachol-induced activity to be higher in models of autism compared to controls. 
We compared VPA-exposed mice to age-matched controls whose mothers had been injected 
with saline at the same timepoint. For FMR1 KO mice, we used age-matched FMR1 WT 
controls. In carbachol, both autism models exhibit a significant increase in the fraction of 
strong correlations relative to controls (Fig. 3A,B). Notably, levels of carbachol-induced 
activity were essentially identical in FMR1 WT and KO mice (4.2 ± 0.3% and 4.3 ± 0.4% in 
WT and KO respectively), demonstrating that the abnormally high correlations we observed 
during carbachol-induced activity in FMR1 KO mice are not simply an artifact of 
differences in activity. By contrast, levels of carbachol-induced activity were different for 
VPA-exposed mice and their wildtype controls, but once again, accounting for these 
differences could not explain the abnormally increased strong correlations observed in VPA-
exposed mice (Fig. S2C; Fig. S3).
Finally, we evaluated whether this abnormal increase in correlations during carbachol-
induced activity possesses specificity for autism. For this, we examined genetic and 
pharmacologic perturbations that affect the PFC but do not model autism: mice expressing a 
dominant negative version of DISC1 in excitatory neurons (CaMKII-TTA / TetO-dnDISC1), 
and mice chronically treated with the commonly prescribed selective-serotonin reuptake 
inhibitor fluoxetine. DISC1 disruption models aspects of schizophrenia and depression, 
including behaviors related to PFC dysfunction, e.g. impaired working memory and 
decreased social interaction (28-30). Chronic treatment with fluoxetine alters cell 
proliferation in the mPFC (31) in ways that may contribute to its effects on depression-like 
and repetitive behaviors. If the changes we saw in VPA-exposed and FMR1 KO mice were 
simply nonspecific consequences of perturbing PFC microcircuits, then we would expect 
these other mice to exhibit a similar increase in correlations during carbachol-induced 
activity. However, we observed no such increase in correlations during carbachol-induced 
activity in either of these cases compared to controls (Fig. 3C, D).
DISCUSSION
In this study we have identified a putative microcircuit level-phenotype associated with 
autism: a defect in the ability of cholinergic modulation to decorrelate spontaneous cortical 
circuit activity. We show that this decorrelation, previously observed in vivo, can also be 
observed at the level of isolated cortical microcircuits, and that it is lost in two mouse 
models of autism. Lastly, we show that this defect is at least somewhat specific for autism, 
as it is not present following two other manipulations that affect prefrontal cortex: chronic 
treatment with fluoxetine, and expression of a dominant-negative form of DISC1. This 
suggests that the loss of cholinergic-dependent decorrelation observed might represent a 
microcircuit-level phenotype with specificity for autism, and thus could constitute an 
attractive target for novel circuit level-therapies.
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Relationship to in vivo studies
While we have shown the cholinergic decorrelation to be present in vitro, it will be 
important to compare our findings to features of activity occurring in vivo. That being said, 
in vivo recordings address fundamentally different questions from those addressed here. 
Activity in vivo is strongly influenced by synaptic inputs originating outside the local 
microcircuit as well as factors such as behavior state. Thus, while in vivo studies are 
uniquely able to identify network phenomena, e.g., decorrelations recruited by attention (5, 
6) and acetylcholine (7), they are not well suited for determining how these phenomena 
relate to local microcircuit mechanisms. For example, even if it were possible to precisely 
control levels of neuromodulation in vivo, doing so would almost certainly elicit 
confounding changes in feedforward and feedback inputs. Here, by studying isolated 
microcircuits within brain slices, we demonstrate unequivocally that the decorrelations 
observed in vivo can emerge as a result of cholinergic modulation acting directly on 
microcircuits. (Interestingly, whereas we studied ongoing patterns of spontaneous network 
activity similar to those believed to mediate attentional effects in vivo, another recent in vitro 
study (4) showed that acetylcholine decorrelates the latency to the first spike in 
somatosensory neurons responding to thalamic input).
We go on to demonstrate that the carbachol-induced decorrelation of spontaneous network 
activity we found is disrupted in models of autism. If one observed abnormal correlations in 
models of autism in vivo, it would be unclear whether these abnormalities reflect the 
inability of cholinergic modulation to decorrelate local circuits (as we have found) vs. more 
macroscopic deficits, e.g. the inability of these animals to engage the appropriate behavioral 
state. Our approach is specifically intended to isolate and examine the integrity of specific 
microcircuit mechanisms, in a way that complements in vivo work. Our focus on 
mechanisms that are intrinsic to deep layer prefrontal circuits is particularly relevant given 
that these circuits represent the single strongest locus of convergence for autism genes (1).
Relevance to autism
Great progress has been made in identifying genes and environmental factors that contribute 
to autism. However, it has been challenging to understand how all of these “add up” to alter 
circuit activity in ways that could impact behavior. Cortical microcircuits, within which 
many cell types and synapses interact to generate patterns of neural activity, represent an 
attractive locus at which at which many different genetic, environmental, and developmental 
lesions could converge to elicit common phenotypes. Thus, many studies have begun 
exploring possible circuit-level endophenotypes for complex neuropsychiatric disorders 
including autism (32-34).
As discussed above, attentional deficits are a major feature of autism generally, and Fragile 
X syndrome in particular. The failure of cholinergic modulation to decorrelate PFC 
microcircuit activity in autism models holds face validity as a possible contributor to these 
deficits. The presence of this same abnormality in two models of autism with very different 
etiologies (but not in association with other manipulations of prefrontal function) provides 
additional empirical validity for the hypothesis that this abnormality plays a role in the 
pathophysiology of autism. Importantly, this circuit-level abnormality may come about as a 
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result of multiple, dissimilar cellular and synaptic effects in FMR1 KO and VPA-exposed 
mice. Indeed, as stated earlier, numerous autism-related genes are convergently expressed 
within the deep layer PFC circuits we have shown are abnormal (1). This highlights the 
importance of identifying microcircuit-level phenotypes, such as the loss of cholinergic 
decorrelation, that could represent convergent consequences of disruptions in multiple 
genes, and which could plausibly contribute to common aspects of autism, e.g. attentional 
deficits.
Possible circuit mechanisms
Of course, it will still be important to identify the cellular and/or synaptic actions of 
cholinergic modulation which normally help desynchronize microcircuit activity, but are 
abnormal in VPA-exposed and/or FMR1 KO mice. Various studies have shown that 
cholinergic modulation can increase the excitability of interneurons which express 
somatostatin or vasoactive intestinal peptide (35, 36), hyperpolarize fast-spiking 
interneurons (36), regulate short-term plasticity at both excitatory and inhibitory synapses 
(37), preferentially elicit persistent firing in subcortically-projecting (vs. callosally-
projecting) L5 pyramidal neurons (38), and suppress intracortical (but not thalamocortical) 
excitatory synapses (39). Of course, it remains unclear whether each of these effects is 
present in the prefrontal circuits we have studied, contributes to the cholinergic-ineduced 
decorrelation we have found, and/or is altered in FMR1 KO and VPA-exposed mice.
Rather than to explore each of these effects individually, we instead took the unconventional 
approach of developing a new assay, using it to examine whether all the effects of 
cholinergic modulation add up to exert some net influence on circuit activity, and then 
evaluating whether that net circuit-level influence is altered in a consistent way across VPA-
exposed and FMR1 KO mice. Examining individual cellular and synaptic effects of 
cholinergic modulation would be time consuming, and might miss the “big picture” of how 
diverse abnormalities can add up to elicit a common, circuit-level phenotype. By contrast, 
the approach demonstrated here can explore how various factors shape pairwise 
decorrelation and other emergent network properties. For example, one could combine 
optogenetic inhibition of genetically targeted cell populations with GCaMP imaging to 
explore how specific cell types influence network correlation / decorrelation.
Conclusions
By describing a potential new microcircuit-level phenotype for autism, our study builds a 
critical foundation for future work to elucidate the detailed pathways, leading from the 
FMR1 gene or VPA exposure, to the abnormal response of prefrontal microcircuits to 
cholinergic modulation we have found. One could also evaluate potential therapies by 
measuring how well they improve the ability of cholinergic modulation to decorrelate these 
circuits – this approach might reveal novel therapeutic strategies that bypass the molecular 
pathways disrupted in autism, and instead exploit alternative mechanisms to normalize 
overall circuit function.
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Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Single photon GCaMP imaging resolves simultaneous activity from many neurons in 
prefrontal slices
a, Regions of Interest (ROIs) obtained by an automated algorithm, showing the locations of 
neurons, superimposed on the maximum standard deviation projection of a GCaMP6s 
movie .
b, Sample GCaMP6s signals from 8 neurons (out of 84 total neurons imaged). Overlaid red 
lines indicate times when we detected that a neuron was active.
c, Example raster of spontaneous network activity for a single 60 min experiment with 84 
neurons.
d, Cumulative probability distributions for correlations in real datasets (black line; n = 29 
experiments from wild-type mice) vs. those observed in data shuffled by shifting each 
neuron's event train by a different random amount (“shuffled”, purple line) or by randomly 
reassigning the neuronal identity associated with each event (“scrambled”, blue line). Inset: 
the fraction of correlations > 0.15 are shown for real and shuffled / scrambled datasets. In 
each case, both the individual datapoints as well as the means and standard errors are shown.
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Figure 2. Cholinergic modulation decorrelates microcircuit activity in wild-type mice, but not in 
models of autism
a. Cumulative distribution of pairwise correlations for FMR1 WT datasets using either 2 μM 
carbachol (n = 7) or high K+ ACSF to elicit activity (n = 6). Inset: In carbachol, there are 
fewer strong correlations (>0.15) compared to high K+ ACSF (p < 0.01).
b, Cumulative distribution plot for correlations recorded from FMR1 KO mice in carbachol 
(green line) or high K+ ACSF (black line). Inset: In carbachol, there is no reduction in strong 
correlations (>0.15), compared to high K+ ACSF. Both individual datapoints as well as the 
means and standard errors are shown.
c, Cumulative distribution plot for correlations recorded from VPA-exposed mice in 
carbachol (red line) or high K+ ACSF (black line). Inset: In carbachol, there are more strong 
correlations (>0.15), compared to high K+ ACSF. Both individual datapoints as well as the 
means and standard errors are shown.
d, Scatterplot of the fraction of strong correlations as a function of the fraction of time active 
for WT datasets in carbachol (black O symbols) or high K+ ACSF (brown X symbols). The 
gray dashed line represents a linear fit of all points (carbachol and high K+ ACSF).
e, Residual values for the fractions of strong correlations, i.e. the difference between the 
actual values, and the fraction expected based on a linear relationship between activity and 
strong correlations, for carbachol (black) and high K+ ACSF (brown) datasets. Even after 
accounting for a possible relationship between activity and strong correlations, the fraction 
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of strong correlations in high K+ ACSF is still significantly greater than in carbachol. ** p 
<0.01 by Wilcoxon rank sum test
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Figure 3. Autism models, but not DISC1 mutant or fluoxetine-treated mice, exhibit abnormally 
elevated correlations in carbachol
a, Left: Plot of the average amount of time each neuron was active for FMR1 WT (filled 
black circles, left; n=7) or FMR1 KO slices (filled green circles, right; n=6). Right: 
Cumulative distribution of correlations, averaged over all experiments in FMR1 WT (black; 
n=7) or FMR1 KO slices (green; n=6). Inset shows fraction of strong correlations, i.e. values 
> 0.15 for each condition, and both individual datapoints as well as the means and standard 
errors are plotted.
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b, Similar to a, but compares experiments in saline-exposed (black; n=9) or VPA-exposed 
slices (orange; n=12).
c, Similar to a, but compares experiments in control (black circles, left; n=8) vs. dominant 
negative DISC1 mutant mice (blue circles, right; n=6).
d, Similar to a, but compares experiments in saline-treated (black circles, left; n=6) 
compared to FLX-treated mice (purple circles, right; n=7).
** p < 0.01 by Wilcoxon ranksum test.
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Table 1
List of all experiments along with summary statistics describing network activity.
Genotype/Condition Background Bath condition No. Slices No. Mice No. Cells % time active Fraction 
pairs > 0.15
GCaMP6s
VPA VPA exposed C57B16 2μM Carbacho 1 11 7 64 ± 2.3 1.4 ± 0.1 0.094 ± 0.010
VPA exposed C57B16 ‘active’ ACSF 10 6 83 ± 2.3 3.1 ± 0.3 0.043 ± 0.009
saline exposed controls C57B16 2μM Carbacho 1 7 4 76 ± 4.2 2.8 ± 0.3 0.039 ± 0.009
FMR1 FMR1 KO FVB1 2μM Carbacho 1 6 4 83 ± 1.8 4.3 ± 0.4 0.045 ± 0.015
FMR1 WT FVB1 2μM Carbacho 1 7 4 86 ± 1.8 4.2 ± 0.3 0.012 ± 0.003
FMR1 KO FVB1 ‘active’ ACSF 12 7 85 ± 1.6 5.6 ± 0.4 0.026 ± 0.005
FMR1 WT FVB1 ‘active’ ACSF 6 3 80 ± 2.4 4.5 ± 0.5 0.040 ± 0.009
FLX Fluoxetine injected C57B16 2μM Carbacho 1 8 6 85 ± 1.3 4.1 ± 0.2 0.010 ± 0.002
Saline injected C57B16 2μM Carbacho 1 6 5 78 ± 1.7 3.6 ± 0.8 0.033 ± 0.018
DISC1dn CamKII::ttA / tetO - 
DISC1dn
C57B16 2μM Carbacho 1 6 3 86 ± 2.4 3.8 ± 0.3 0.020 ± 0.009
tetO - DISC1dn/ + C57B16 2μM Carbacho 1 2 2 86 ± 0.5 3.2 ± 0.1 0.016 ± 0.005
CamKII :: ttA / + C57Bl6 2μM Carbacho 1 4 3 83 ± 3.5 3.7 ± 0.8 0.011 ± 0.004
+/+ C57Bl6 2μM Carbacho 1 3 3 89 ± 4.0 3.3 ± 0.5 0.008 ± 0.003
All values shown as mean with SEM
Each row describes a single experimental condition. Mice that correspond to controls and experimental manipulations (e.g. FMR1 WT and KO 
mice) are listed together. In addition to the experimental condition, we present the background for all mice, the bath condition used to elicit activity 
(either carbachol or active ACSF), the number of cells in each experiment, the % time that each cell was active, and the fraction of pairwise 
correlations between neurons that exceed 0.15. All data show represent means across an experimental condition ± one S.E.M.
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